Posttranscriptional regulation of TSC-22 (TGF-β-stimulated clone-22) gene by TGF-β1

Biochemical and Biophysical Research Communications

Volumn 305, Issue 4, 2003, Pages 846-854

  Uchida, Daisuke ^a   Omotehara, Fumie ^b   Nakashiro, Koh Ichi ^a   Tateishi, Yoshihisa ^a   Hino, Satoshi ^a   Begum, Nasima Mila ^a   Fujimori, Takahiro ^b   Kawamata, Hitoshi ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

AU rich element; mRNA stability; Salivary gland cancer; TSC 22

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; EXON; GENE ACTIVATION; GENE CONTROL; GENE ISOLATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0038581167     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00854-4     Document Type: Article

References (50)

1. Kawamata H., Nakashiro K., Uchida D., Hino S., Omotehara F., Yoshida H., Sato M. Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell. Br. J. Cancer. 77:1998;71-78.
2. Nakashiro K., Kawamata H., Hino S., Uchida D., Miwa Y., Hamano H., Omotehara F., Yoshida H., Sato M. Down-regulation of TSC-22 (transforming growth factor β-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo. Cancer Res. 58:1998;549-555.
3. Uchida D., Kawamata H., Omotehara F., Miwa Y., Hino S., Begum N.M., Yoshida H., Sato M. Over-expression of TSC-22 (TGF-β stimulated clone-22) markedly enhances 5-fluorouracil-induced apoptosis in a human salivary gland cancer cell line. Lab. Invest. 80:2000;955-963.
4. Omotehara F., Uchida D., Hino S., Begum N.M., Yoshida H., Sato M., Kawamata H. In vivo enhancement of chemosensitivity of human salivary gland cancer cells by overexpression of TGF-β stimulated clone-22. Oncol. Rep. 7:2000;737-740.
5. Hino S., Kawamata H., Uchida D., Omotehara F., Miwa Y., Begum N.M., Yoshida H., Sato M. Nuclear translocation of TSC-22 (TGF-β-stimulated clone-22) concomitant with apoptosis: TSC-22 as a putative transcriptional regulator. Biochem. Biophys. Res. Commun. 278:2001;659-664.
6. Shibanuma M., Kuroki T., Nose K. Isolation of a gene encoding a putative leucine zipper structure that is induced by transforming growth factor β1 and other growth factors. J. Biol. Chem. 267:1992;10219-10224.
7. Hamil K.G., Hall S.H. Cloning of rat Sertoli cell follicle-stimulating hormone primary response complementary deoxyribonucleic acid: regulation of TSC-22 gene expression. Endocrinology. 134:1994;1205-1212.
8. Ohta S., Shimekake Y., Nagata K. Molecular cloning and characterization of a transcription factor for the C-type natriuretic peptide gene promoter. Eur. J. Biochem. 242:1996;460-466.
9. Kester H.A., van der Leede B.-J.M., van der Saag P.T., van der Burg B. Novel progesterone target genes identified by an improved differential display technique suggest that progestin-induced growth inhibition of breast cancer cells coincides with enhancement of differentiation. J. Biol. Chem. 272:1997;16637-16643.
10. Trenkle T., Welsh J., Jung B., Mathieu-Daude F., McClelland M. Non-stoichiometric reduced complexity probes for cDNA arrays. Nucleic Acids Res. 26:1998;3883-3891.
11. Kester H.A., Blanchetot C., den Hertog J., van der Saag P.T., van der Burg B. Transforming growth factor-β-stimulated clone-22 is a member of a family of leucine zipper proteins that can homo- and heterodimerize and has transcriptional repressor activity. J. Biol. Chem. 274:1999;27439-27447.
12. Treisman J.E., Lai Z.C., Rubin G.M. Shortsighted acts in the decapentaplegic pathway in Drosophila eye development and has homology to a mouse TGF-β-responsive gene. Development. 121:1995;2835-2845.
13. Kania A., Salzberg A., Bhat M., D'Evelyn D., He Y., Kiss I., Bellen H.J. P-element mutations affecting embryonic peripheral nervous system development in Drosophila melanogaster. Genetics. 139:1995;1663-1678.
14. Dobens L.L., Peterson J.S., Treisman J., Raftery L.A. Drosophila bunched integrates opposing DPP and EGF signals to set the operculum boundary. Development. 127:2000;754.
15. Dohrmann C.E., Belaoussoff M., Raftery L.A. Dynamic expression of TSC-22 at sites of epithelial-mesenchymal interactions during mouse development. Mech. Dev. 84:1999;147-151.
16. Kester H.A., Ward-van Oostwaard T.M., Goumans M.J., van Rooijen M.A., van der Saag P.T., van der Burg B., Mummery C.L. Expression of TGF-β stimulated clone-22 (TSC-22) in mouse development and TGF-β signalling. Dev. Dyn. 218:2000;563-572.
17. Massagué J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
18. Markowitz S., Wang J., Myeroff L., Parsons R., Sun L., Lutterbaugh J., Fan R.S., Zborowska E., Kinzler K.W., Vogelstein B., Brattain M., Willson J.K.V. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science. 268:1995;1336-1338.
19. Eppert K., Scherer S.W., Ozcelik H., Pirone R., Hoodless P., Kim H., Tsui L.C., Bapat B., Gallinger S., Andrulis I.L., Thomsen G.H., Wrana J.L., Attisano L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell. 86:1996;543-552.
20. Hata A., Lo R.S., Wotton D., Lagna G., Massagué J. Mutations increasing autoinhibition inactivate tumour suppressors Smad2 and Smad4. Nature. 388:1997;82-87.
21. Dai J.L., Turnacioglu K.K., Schutte M., Sugar A.Y., Kern S.E. Dpc4 transcriptional activation and dysfunction in cancer cells. Cancer Res. 58:1998;4592-4597.
22. Elbendary A., Berchuck A., Davis P., Havrilesky L., Bast R.C., Iglehart J.D., Marks J.R. Transforming growth factor β1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ. 5:1994;1301-1307.
23. Li J.-M., Nichols M.A., Chandrasekharan S., Xiong Y., Wang X.-F. Transforming growth factor β activates the promoter of cyclin-dependent kinase inhibitor p15INK4B through an Sp1 consensus site. J. Biol. Chem. 270:1995;26750-26753.
24. Keski-Oja J., Raghow R., Sawdey M., Loskutoff D.J., Postlethwaite A.E., Kang A.H., Moses H.L. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-β. Divergent responses in lung fibroblasts and carcinoma cells. J. Biol. Chem. 263:1998;3111-3115.
25. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
26. Shi Y., Wang Y.F., Jayaraman L., Yang H., Massagué J., Pavletich N.P. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell. 94:1998;585-594.
27. ′ -untranslated region of the hyaluronan receptor RHAMM mRNA J. Biol. Chem. 271:1996;15279-15284.
28. Murakami S., Nifuji A., Noda M. Expression of Indian hedgehog in osteoblasts and its posttranscriptional regulation by transforming growth factor-β Endocrinology. 138:1997;1972-1978.
29. Sehgal I., Thompson T.C. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-β1 in human prostate cancer cell lines. Mol. Biol. Cell. 10:1999;407-416.
30. Sheng H., Shao J., Dixon D.A., Williams C.S., Prescott S.M., DuBois R.N., Beauchamp R.D. Transforming growth factor-β1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J. Biol. Chem. 275:2000;6628-6635.
31. Yanagawa T., Hayashi Y., Yoshida H., Yura Y., Nagamine S., Bando T., Sato M. An adenoid squamous carcinoma-forming cell line established from an oral keratinizing squamous cell carcinoma expressing carcinoembryonic antigen. Am. J. Pathol. 124:1986;496-509.
32. Jurka J., Klonowski P., Dagman V., Pelton P. CENSOR-a program for identification and elimination of repetitive elements from DNA sequences. Comput. Chem. 20:1996;119-122.
33. Maruyama K., Sugano S. Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene. 138:1994;171-174.
34. Nakao A., Imamura T., Souchelnytskyi S., Kawabata M., Ishisaki A., Oeda E., Tamaki K., Hanai J., Heldin C.H., Miyazono K., Dijke P.T. TGF-β receptor-mediated signalling through Smad2, Smad3 and Smad4. EMBO J. 16:1997;5353-5362.
35. Jay P., Ji J.W., Marsollier C., Taviaux S., Berge-Lefranc J.-L., Berta P. Cloning of the human homologue of the TGF β-stimulated clone 22 gene. Biochem. Biophys. Res. Commun. 222:1996;821-826.
36. Johnson P.F., McKnight S.L. Eukaryotic transcriptional regulatory proteins. Annu. Rev. Biochem. 58:1989;799-839.
37. ′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation Cell. 46:1986;659-667.
38. Esteller M., Corn P.G., Baylin S.B., Herman J.G. A gene hypermethylation profile of human cancer. Cancer Res. 61:2001;3225-3229.
39. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 16:2000;168-174.
40. Esteller M., Sparks A., Toyota M., Sanchez-Cespedes M., Capella G., Peinado M.A., Gonzalez S., Tarafa G., Sidransky D., Meltzer S.J., Baylin S.B., Herman J.G. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res. 60:2000;4366-4371.
41. Sato M., Harada K., Yoshida H. Induction of differentiation and apoptosis, and LeY antigen expression by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line. Acta Histochem. Cytochem. 27:1994;591-599.
42. Sato M., Harada K., Yura Y., Bando T., Azuma M., Kawamata H., Iga H., Yoshida H. Induction of tumor differentiation and apoptosis, and LeY antigen expression in treatment with differentiation inducing agent, vesnarinone, of a patient with sarivary adenoid cystic carcinoma. Apoptosis. 2:1997;106-113.
43. He L.Z., Merghoub T., Pandolfi P.P. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications. Oncogene. 18:1999;5278-5292.
44. Prasad K.N., Sinha P.K. Effect of sodium butyrate on mammalian cells in culture: a review. In Vitro. 12:1976;125-132.
45. Costa-Giomi M.P., Gaub M.P., Chambon P., Abarzua P. Characterization of a retinoic acid responsive element isolated by whole genome PCR. Nucleic Acids Res. 20:1992;3223-3232.
46. Chilco P.J., Gerardi J.M., Kaczmarczyk S.J., Chu S., Leopold V., Zajac J.D. Calcitonin increases transcription of parathyroid hormone-related protein via cAMP. Mol. Cell. Endocrinol. 94:1993;1-7.
47. Sato M., Kawamata H., Harada K., Nakashiro K., Ikeda Y., Gohda H., Yoshida H., Nishida T., Ono K., Kinoshita M., Adachi M. Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene. Cancer Lett. 112:1997;181-189.
48. Omotehara F., Kawamata H., Uchida D., Hino S., Nakashiro K., Fujimori T. Vesnarinone, a differentiation inducing drug, directly activites p21waf1 gene promoter via Sp1 sites in a human salivary gland cancer cell line. Br. J. Cancer. 87:2002;1042-1046.
49. Massagué J., Wotton D. Transcriptional control by the TGF-β/Smad signaling system. EMBO J. 19:2000;1745-1754.
50. ′ -untranslated region of mRNA molecules specifying inflammatory mediators Proc. Natl. Acad. Sci. USA. 83:1986;1670-1674.